Atherosclerosis
Volume 199, Issue 2 , Pages 362-367, August 2008

Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients

  • M. Mashavi

      Affiliations

    • Department of Medicine, Wolfson Medical Center, Tel Aviv, Israel
    • Department of Diabetes, Wolfson Medical Center, Tel Aviv, Israel
    • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • R. Hanah

      Affiliations

    • Department of Medicine, Wolfson Medical Center, Tel Aviv, Israel
  • ,
  • M. Boaz

      Affiliations

    • Department of Epidemiology and Statistics, Wolfson Medical Center, Tel Aviv, Israel
  • ,
  • D. Gavish

      Affiliations

    • Department of Medicine, Wolfson Medical Center, Tel Aviv, Israel
    • Bruner Institute for Cardiovascular Research, Tel Aviv University, Tel Aviv, Israel
    • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
  • ,
  • Z. Matas

      Affiliations

    • Department of Biochemistry, Wolfson Medical Center, Tel Aviv, Israel
  • ,
  • A. Fux

      Affiliations

    • Department of Biochemistry, Wolfson Medical Center, Tel Aviv, Israel
  • ,
  • M. Shargorodsky

      Affiliations

    • Department of Diabetes, Wolfson Medical Center, Tel Aviv, Israel
    • Department of Endocrinology, Wolfson Medical Center, Tel Aviv, Israel
    • Bruner Institute for Cardiovascular Research, Tel Aviv University, Tel Aviv, Israel
    • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationCorresponding author at: Wolfson Medical Center, POB 5, Holon 58100, Israel. Tel.: +972 3 5028614; fax: +972 3 5032693.

Received 23 July 2007; received in revised form 25 October 2007; accepted 28 November 2007. published online 21 January 2008.

Abstract 

Metformin may affect the risk of atherothrombotic disease. However, metformin increases levels of homocysteine (Hcy), considered an independent risk factor for atherosclerosis. We evaluate whether homocysteine-lowering has a beneficial effect on arterial elasticity and metabolic parameters in metformin-treated diabetic patients. In double-blind, placebo-controlled study, 60 diabetic patients treated with high dose of metformin were randomly assigned to receive daily oral supplementation with folate (1000mcg), vitamins B12 (400mcg) and B6 (10mg) (group 1) or placebo (group 2). Lipid profile, HbA1C, insulin, C-peptide, hs-CRP, vitamin B12, folic acid, homocysteine, endothelin, homeostasis model assessment-insulin resistance (HOMA-IR) were measured. Arterial elasticity was evaluated using pulse wave contour analysis (HDI CR 2000, Eagan, MN). The two groups were similar at baseline in terms of hemodynamic and arterial elasticity parameters. After a 4-month small artery elasticity index (SAEI) was significantly greater in patients who received Hcy-lowering agents than in the placebo group: 4.3±2.04ml/mmHg×100 versus 3.2±1.1ml/mmHg×100, p=0.01. Post-treatment vitamin B12 and folic acid levels were greater in group 1 versus group 2: 738.1±279.9pg/ml versus 566.1±167.4pg/ml, p=0.007 and 14.9±4.8ng/ml versus 8.3±2.9ng/ml, p<0.0001, respectively. Hcy level decreased significantly in the treatment group from 10.0±4.4 to 7.6±2.5μmol/l, p=0.002 and did not change in placebo group (p=0.9). Hcy-lowering therapy improved small arterial elasticity in diabetic patients treated with high dose of metformin. The improvement was associated with a decrease in Hcy as well as an increase in folic acid and vitamin B12. These findings suggest that Hcy-lowering may have beneficial vascular effect in metformin-treated diabetic patients.

Keywords: Homocysteine, Atherosclerosis, Arterial elasticity, Pulse wave contour analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(07)00764-2

doi:10.1016/j.atherosclerosis.2007.11.037

Atherosclerosis
Volume 199, Issue 2 , Pages 362-367, August 2008